All Stories

  1. Eczema‐Like Amelanotic Melanoma: A Diagnostic Challenge
  2. European S2k guidelines for hidradenitis suppurativa/acne inversa Part 1. Epidemiology, diagnosis and clinical assessment
  3. Balneotherapy as Adjunctive Care in Atopic Dermatitis: Effects on Skin Barrier, Microbiome, and Pruritus
  4. Organization of skin ulcer outpatient clinics in Italy: results from a survey of the Study Group on Ulcers of the Italian Society of Dermatology and Venereology
  5. Bridging Pathophysiology and Clinical Practice: The Role of Oleic Matrices in Wound Healing
  6. Potential role of tirbanibulin in the management of superficial basal cell carcinoma
  7. Exploring β3-Adrenergic Receptor, HIF-1α, and CD31 Interplay in the Microenvironment of Atypical Melanocytic Lesions
  8. Biosensor Technologies and Smart Dressings for Chronic Wound Monitoring: A Systematic Review
  9. Neoplastic Foot Ulcers: A Multicentre Retrospective Study
  10. Scalp Melanoma in a Young Patient With Systemic Sarcoidosis: Multidisciplinary Approach
  11. Ultra‐high frequency ultrasound predicts baricitinib response in alopecia areata: Towards personalized treatment
  12. Effectiveness and safety of baricitinib in severe alopecia areata: 48‐week results
  13. Efficacy and safety of a medical device based on hyaluronic acid and amino acids for the topical treatment of hard-to-heal skin ulcers: a pilot clinical trial
  14. Upadacitinib dose adjustment in moderate‐to‐severe atopic dermatitis: insights from a multicenter real‐world study
  15. Assessing the burden of dermatological diseases on work life from a gender perspective
  16. Correlation Between Ultra‐High Frequency Ultrasound (UHFUS) and Histological Features of Typical Lesions in Hidradenitis Suppurativa
  17. Prurigo Nodularis at Ultra-High-Frequency Ultrasound
  18. Foliage Intense Filler, Affects Nasolabial Folds Wrinkles: Effectiveness and Safety by Prospective Comparative Study
  19. Recalcitrant Grover's disease treated with dupilumab: two long‐term cases and review of the literature
  20. Clinical impact of zinc oxide compression bandaging in chronic venous disease assessed with ultrasonography and trans-epidermal water loss – preliminary observations
  21. Incidence of therapy switch in patients with moderate to severe palmoplantar psoriasis treated with anti-IL 17 and anti-IL 23 monoclonal antibodies: a retrospective observational study
  22. Ultra-High Frequency Ultrasound (UHFUS) Features of Pyoderma Gangrenosum, Venous Leg Ulcers, and Acute Ulcerative Lesions
  23. High-Frequency and Ultra-High-Frequency Ultrasound in Dermatologic Diseases and Aesthetic Medicine
  24. Correlation between skin cancer and therapy with anti-IL monoclonal antibodies in patients affected by moderate-to-severe psoriasis: an observational monocentric study
  25. Tirbanibulin in actinic keratosis treatment: evaluation of effectiveness, safety and patients’ satisfaction in a comparison with cryotherapy
  26. High-Frequency and Ultra-High-Frequency Ultrasound in Dermatologic Diseases and Aesthetic Medicine
  27. Effectiveness of wide local excision and secondary intention healing in hidradenitis suppurativa: a single-centre study on quality of life and mental health outcomes
  28. Paradoxical Eczematous Eruptions in Patients with Psoriasis Treated with Biological Therapy
  29. Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study
  30. Cord Blood Serum Levels of IL-31 and CCL17, Cutaneous Markers, and Development of Atopic Dermatitis
  31. Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
  32. Interleukin‐1 family cytokines and soluble receptors in hidradenitis suppurativa
  33. Evaluation of post-surgical complications of hidradenitis suppurativa lesions explored with presurgical ultra-high frequency ultrasound mapping
  34. Melanocytic nevi changes during pregnancy: What to do?
  35. Effectiveness of guselkumab in patients with facial and/or genital psoriasis: Interim analysis results at Week 12 from the GULLIVER study
  36. Risankizumab as a Therapeutic Approach for Recalcitrant Pyoderma Gangrenosum
  37. Switch from adalimumab to brodalumab as a possible trigger factor for the onset of pyoderma gangrenosum
  38. Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study
  39. International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab
  40. Fluorescence-Based Evaluation of Bacterial Load in Perilesional Skin: A Comparison Between Short Stretch Bandage and Zinc Oxide Bandage
  41. The Role of Ultra-High-Frequency Ultrasound in Pyoderma Gangrenosum: New Insights in Pathophysiology and Diagnosis
  42. Ultra-High-Frequency Ultrasound as an Innovative Imaging Evaluation of Hyaluronic Acid Filler in Nasolabial Folds
  43. Ultra-High Frequency UltraSound (UHFUS) Assessment of Barrier Function in Moderate-to-Severe Atopic Dermatitis during Dupilumab Treatment
  44. Assessment and Monitoring of Nail Psoriasis with Ultra-High Frequency Ultrasound: Preliminary Results
  45. The diagnosis, management and prevention of intertrigo in adults: a review
  46. Pso-Reg: a web registry for psoriasis in real life
  47. Compression Therapy in Dermatology
  48. An Integrated Systemic and Local Wound Management in Recalcitrant Pyoderma Gangrenosum
  49. Pyoderma Gangrenosum in a Patient With Dubowitz Syndrome: a New Comorbidity?
  50. A Phase IIIb, Multicentre, Interventional, Randomised, Placebo‐Controlled Clinical Trial Investigating the Efficacy and Safety of Guselkumab for the Treatment of Nonpustular Palmoplantar Psoriasis (G‐PLUS)
  51. Serum Amyloid A: A Potential New Marker of Severity in Hidradenitis Suppurativa
  52. Ultra‐High Frequency Ultrasound in Melanoma Management
  53. National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis
  54. Secukinumab demonstrated sustained retention, effectiveness and safety in a real‐world setting in patients with moderate‐to‐severe plaque psoriasis: long‐term results from an interim analysis of the SERENA study
  55. The Role of Autoflorescence Imaging Device in the Evaluation of Bacteria Burden Control
  56. The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma
  57. Parasites causing cutaneous wounds: Theory and practice from a dermatological point of view
  58. Impact of psychiatric comorbidities in psoriasis, hidradenitis suppurativa and atopic dermatitis: The importance of a psychodermatological approach
  59. Oral ivermectin: a feasible alternative to topical therapy of genital scabies
  60. Adherence and Persistence to Biological Drugs for Psoriasis: Systematic Review with Meta-Analysis
  61. A real‐life experience as a proof of Guselkumab effectiveness and safety in patients with moderate to severe psoriasis
  62. Family history of psoriasis: a novel protective factor for therapy switch in patients treated with Secukinumab or Ixekizumab
  63. Palliative Management of a Recurrent Destructive Cutaneous Squamous Cell Carcinoma of the Scalp With Brain Exposure
  64. Blue light emission in the management of hard-to-heal wounds
  65. Local Management of Malignant and Unresectable Fungating Wounds: PEBO Assessment
  66. Effect of dupilumab on genital condylomata: a case report
  67. Echoentomography for Assessing Braconid Parasitization on Soft-Bodied Tephritid Hosts
  68. Umbilical giant condyloma acuminatum
  69. Unusual presentation of angiolymphoid hyperplasia with eosinophilia treated with intralesional and topic corticosteroid combination therapy
  70. Ultra-high-frequency ultrasound monitoring of melanomas arising in congenital melanocytic nevi: a case series
  71. Risk factors in pediatric melanoma: a retrospective study of 39 cases
  72. Ultrasound‐guided injection of intralesional steroids in acute hidradenitis suppurativa lesions: A prospective study
  73. Seborrheic keratosis-like melanoma: a diagnostic challenge
  74. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review
  75. Evaluation of neutrophil extracellular trap deregulated formation in pyoderma gangrenosum
  76. The Association Between pH and Fluorescence as Noninvasive Diagnostic Tools in Chronic Wounds
  77. Ultra‐high‐frequency ultrasound and machine learning approaches for the differential diagnosis of melanocytic lesions
  78. Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack‐year on the response to therapy
  79. Ultra‐high‐frequency ultrasound monitoring of plaque psoriasis during ixekizumab treatment
  80. Wound Dehiscence After Achilles Tendon Trauma and Repair: Treatment With Ultraportable Negative Pressure Wound Therapy and Compression Therapy
  81. The potential role of propranolol in incontinentia pigmenti
  82. Improvement of severe facial seborrheic dermatitis following low-dose isotretinoin therapy
  83. Gynecomastia following isotretinoin treatment: a rare endocrine side effect
  84. 5% Lidocaine Hydrochloride Cream for Wound Pain Relief: A Multicentre Observational Study
  85. Surrounding skin management in venous leg ulcers: A systematic review
  86. Isotretinoin-triggered acne fulminans: a rare, disabling occurrence
  87. Dermatoscopic and ultra‐high frequency ultrasound evaluation in cutaneous postradiation angiosarcoma
  88. PG‐TIME : A practical approach to the clinical management of pyoderma gangrenosum
  89. <p>Using Skin Bioengineering to Highlight How Weight and Diabetes Mellitus Modify the Skin in the Lower Limbs of Super-Obese Patients</p>
  90. Triticum vulgare Extract Modulates Protein-Kinase B and Matrix Metalloproteinases 9 Protein Expression in BV-2 Cells: Bioactivity on Inflammatory Pathway Associated with Molecular Mechanism Wound Healing
  91. Atypical Ulcers: Diagnosis and Management
  92. A giant annular rash in a woodman: the many faces of erythema chronicum migrans
  93. Itch in Chronic Wounds: Pathophysiology, Impact, and Management
  94. Biomodulation induced by fluorescent light energy versus standard of care in venous leg ulcers: a retrospective study
  95. Intraoral Ultra‐High Frequency Ultrasound study of oral lichen planus: A pictorial review
  96. Tuscan consensus on the diagnosis and treatment of hidradenitis suppurativa
  97. Topical purified omental lipid formulations in the prevention of skin ulcers: a narrative review
  98. Potential role of serum amyloid A in hidradenitis suppurativa
  99. Breast surgeons dealing with Munchausen syndrome: A self‐induced necrotic phlegmon of the breast treated with surgery, negative pressure and epidermal fractional skin grafting
  100. Current therapeutic paradigm in pediatric atopic dermatitis: Practical guidance from a national expert panel
  101. Tuscan consensus on the use of UVBnb phototherapy in the treatment of psoriasis
  102. Is it really just a small world?
  103. Sex‐related differences of clinical features in hidradenitis suppurativa: analysis of an Italian‐based cohort
  104. Necrotoxic spider bite: a successful noninvasive wound management
  105. Risankizumab for the treatment of moderate to severe psoriasis
  106. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial
  107. Enhancing daily practice through knowledge sharing
  108. Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group
  109. Cell salvage in acute and chronic wounds: a potential treatment strategy. Experimental data and early clinical results
  110. Acne fulminans associated with lymecycline intake: a case report
  111. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directe
  112. Elderly psoriatic patients under biological therapies: an Italian experience
  113. Catching the vulnologists around the globe
  114. Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries
  115. Long-Term Outcome of Adalimumab in a Young Girl with Hidradenitis Suppurativa
  116. The Hidradenitis Suppurativa (HS) “Multidisciplinary Unit”: a rationale and practical proposal for an organised clinical approach
  117. Optimising collaboration in science and clinical practice
  118. Scanning the Immunopathogenesis of Psoriasis
  119. Intralesional Diode Laser 1064 nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients
  120. Determination of salivary α-amylase and cortisol in psoriatic subjects undergoing the Trier Social Stress Test
  121. Hidradenitis Suppurativa Associated with Down Syndrome Is Characterized by Early Age at Diagnosis
  122. Sensors and Biosensors for C-Reactive Protein, Temperature and pH, and Their Applications for Monitoring Wound Healing: A Review
  123. EUREKA study – the evaluation of real-life use of a biophotonic system in chronic wound management: an interim analysis
  124. A new class of biologic agents facing the therapeutic paradigm in psoriasis: anti-IL-23 agents.
  125. Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus
  126. Biomarkers—an unmet need in wound care
  127. Evaluation of osteopontin expression in chronic wounds: a potential prognostic and therapeutic biomarker
  128. Biomarkers for psoriasis skin lesions
  129. The management of moderate-to-severe chronic plaque psoriasis
  130. Introducing the new WUWHS executive and editorial board
  131. Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy
  132. Temperature and pH sensors based on graphenic materials
  133. Association between HCV infection and cutaneous-mucosal lichen planus: an update
  134. TSLP-activated dendritic cells induce human T follicular helper cell differentiation through OX40-ligand
  135. Retroauricular angiolymphoid hyperplasia with eosinophilia: sustained long-term remission following treatment with corticosteroids
  136. Tuscan consensus on the diagnosis, treatment and follow-up of moderate-to-severe psoriasis
  137. Primary cutaneous diffuse large B-cell lymphoma presenting as chronic non-healing ulcer
  138. Temperature- and pH-sensitive wearable materials for monitoring foot ulcers
  139. Optimizing acitretin use in patients with plaque psoriasis
  140. Contact dermatitis in patients with chronic leg ulcers: a common and neglected problem: a review 2000–2015
  141. No meaningful association between suicidal behavior and the use of IL-17A-neutralizing or IL-17RA-blocking agents
  142. Epidermal skin grafting in vitiligo: a pilot study
  143. Use of advanced technologies across the wound care spectrum: prologue
  144. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
  145. Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis
  146. The world of wounds comes together
  147. Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity
  148. Small molecules and antibodies for the treatment of psoriasis: a patent review (2010–2015)
  149. Recommendations for the management of biofilm: a consensus document
  150. A revolutionary therapeutic approach for psoriasis: bispecific biological agents
  151. Optimizing Technology Use for Chronic Lower-Extremity Wound Healing
  152. A D-optimal design to model the performances of dressings and devices for negative pressure wound therapy
  153. Difficult-to-heal wounds of mixed arterial/venous and venous etiology: a cost-effectiveness analysis of extracellular matrix
  154. What's new: Management of venous leg ulcers
  155. What's new: Management of venous leg ulcers
  156. Erratum: Erratum: Dynamic markers based on blood perfusion fluctuations for selecting skin melanocytic lesions for biopsy
  157. The use of a collagen matrix in hard-to-heal venous leg ulcers
  158. Skin Physiology of the Neonate and Infant: Clinical Implications
  159. Dynamic markers based on blood perfusion fluctuations for selecting skin melanocytic lesions for biopsy
  160. Hidradenitis Suppurativa and Wound Management
  161. Biologic drugs in wound management
  162. Clinical evaluation of the efficacy and safety of a medical device in various forms containing Triticum vulgare for the treatment of venous leg ulcers – a randomized pilot study
  163. Fractional epidermal skin grafting
  164. The role of biomedical sensors in wound healing
  165. Atrophie Blanche
  166. Cryoglobulinemia
  167. SWAN-iCare : prise en charge des plaies de pied diabétique par pression négative et monitoring à distance de la cicatrisation
  168. 24thAnnual Meeting of the European Tissue Repair Society
  169. Quantitative Evaluation of Maceration in Venous Leg Ulcers by Transepidermal Water Loss (TEWL) Measurement
  170. Chronic wound management and research
  171. Physical Therapy in Wound Healing, Edema, and Urinary Incontinence
  172. Livedoid vasculopathy: An in-depth analysis using a modified Delphi approach
  173. Introduction
  174. Cutaneous ulcers associated with hydroxyurea therapy
  175. Dear readers
  176. Cutaneous foetal injuries related to amniocentesis
  177. Improvement of Periulcer Skin Condition in Venous Leg Ulcer Patients
  178. SWAN-iCare: A smart wearable and autonomous negative pressure device for wound monitoring and therapy
  179. Use of diagnostics in wound management
  180. Efficacy of Adalimumab for the Treatment of Refractory Paediatric Acrodermatitis Continua of Hallopeau
  181. Measurements in Wound Healing
  182. A temperature sensor based on a MWCNT/SEBS nanocomposite
  183. Skin and Vascular Assessments
  184. Skin temperature monitoring by a wireless sensor
  185. Classification of Wounds at Risk and Their Antimicrobial Treatment with Polihexanide: A Practice-Oriented Expert Recommendation
  186. Evaluation of the Efficacy and Tolerability of a Solution Containing Propyl Betaine and Polihexanide for Wound Irrigation
  187. Dilemmas in measuring and using pressure ulcer prevalence and incidence: an international consensus
  188. Ibuprofen slow-release foam dressing reduces wound pain in painful exuding wounds: Preliminary findings from an international real-life study
  189. Efficacy and tolerance of a hydrocolloid dressing containing hyaluronic acid for the treatment of leg ulcers of venous or mixed origin
  190. Clinical significance of cutaneous proteoglycan (mucin) infiltration in patients with mitral valve prolapse
  191. Amelogenin, an extracellular matrix protein, in the treatment of venous leg ulcers and other hard-to-heal wounds: Experimental and clinical evidence  ||FREE PAPER||
  192. Use of Nanotechnology-Designed Footsock in the Management of Preulcerative Conditions in the Diabetic Foot: Results of a Single, Blind Randomized Study
  193. Dressing‐related pain in patients with chronic wounds: an international patient perspective
  194. Hip fracture and pressure ulcers – the Pan-European Pressure Ulcer Study – intrinsic and extrinsic risk factors
  195. Hydroxyurea-Induced Leg Ulcers Treated With a Protease-Modulating Matrix
  196. Wound Assessment by 3-Dimensional Laser Scanning
  197. Improvement of Idiopathic Pyoderma Gangrenosum During Treatment With Anti-Tumor Necrosis Factor Alfa Monoclonal Antibody
  198. OASIS�wound matrix versus Hyaloskin�in the treatment of difficult-to-heal wounds of mixed arterial/venous aetiology
  199. Prevention and management of pressure ulcers
  200. Microcirculation - a Blarney Stone to Wound Healing
  201. The effect of amelogenins (Xelma™) on hard-to-heal venous leg ulcers
  202. Cutaneous Tissue Engineering and Lower Extremity Wounds (Part 2)
  203. The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial
  204. Wound bed preparation and a brief history of TIME
  205. Semiquantitative Analysis of the Histopathological Features of the Neuropathic Foot Ulcer: Effects of pressure relief
  206. Angiogenesis and nerve regeneration in a model of human skin equivalent transplant
  207. Wound bed preparation: a systematic approach to wound management
  208. Sodium carboxyl-methyl-cellulose dressings in the management of deep ulcerations of diabetic foot
  209. Hardness of Plantar Skin in Diabetic Neuropathic Feet
  210. Use of a durometer to measure the degree of skin induration in lipodermatosclerosis
  211. The effect of topical nitroglycerin on transcutaneous oxygen